Jiangsu Hengrui Medicine Co., Ltd., established in 1970 and headquartered in Lianyungang, Jiangsu Province, is not only the front-runner in China’s innovative medicine, but also a well-known R&D center of antineoplastics and surgical medicine in China. Taking the slogan that “Science & Technology for a Better Life”，Hengrui Medicine is dedicated to researching, developing, and promoting innovative medicine with high quality. We aim to help doctors solve clinical problems, help patients be cured, and help improve the standard of health for all humanity.
Hengrui Medicine focuses on fulfilling the unmet clinical demands, promoting innovation in technology, and serving the health of humanity. Hengrui Medicine invests 10% of its annual turnovers in research and development, and has constituted a thorough innovation system with R&D centers and clinical division in New Jersey, Shanghai, Chengdu, and Lianyungang. The company specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system. In 2014, Hengrui Medicine independently developed a 1.1 Class innovative medicine named Apatinib, the world’s first small molecule anti-angiogenesis targeting agent to treat late gastric cancer, bringing hope for patients suffering from late stage gastric cancer. Hengrui Medicine welcomes all kinds of high-level talents and professionals from home and abroad and now is equipped with a R&D team of more than 1,300. The diversification of products, comprehensive product lines, and the pursuit of innovation endow us with great competitive advantage.
Hengrui Medicine is committed to producing high quality medicines to help more patients have access to better and affordable medical resources more timely. Adhering to the highest level of the US FDA management standards to manage the production, Hengrui Medicine is the first pharmaceutical enterprise that sells domestic injectable products overseas to Europe, US, and Japan. By taking global coordination, we have been creating more value for our patients and stake holders, and curbed the rapid increase of global health care cost. Hengrui Medicine now produces and sells injectable products, oral dosages, and many other types of medicine in the European and US markets. No matter it is in cities or rural areas, we are more accessible to patients, clinicians, and business partners. Hengrui Medicine has won great reputation and respect by providing high quality and reliable products.
The future depends on the health of people, and it is innovation that establishes a good brand. Hengrui Medicine will take continuous efforts to serve the great cause of human health with more and more new and high quality medicines.